MOTHAFFAR RIMAWI to Homologous Recombination
This is a "connection" page, showing publications MOTHAFFAR RIMAWI has written about Homologous Recombination.
Connection Strength
0.040
-
TBCRC 030: a phase II study of preoperative cisplatin versus paclitaxel in triple-negative breast cancer: evaluating the homologous recombination deficiency (HRD) biomarker. Ann Oncol. 2020 11; 31(11):1518-1525.
Score: 0.040